Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbs as Adjunctive Therapy in MAB-PD
NCT07295938Phase 2Recruiting
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Sep 2025
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 2, randomised trial in Mycobacterium abscessus pulmonary disease (4 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoints: Clinical cure rate at 52 weeks and Relapse or reinfection rates at 52 weeks. Started Sep 2025; status: recruiting.
02
Conditions
Mycobacterium abscessus pulmonary disease
Beyond the preview
Go deeper on NCT07295938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295938.